Immune System Booster Shown Safe For Prostate Cancer; Fewer Side Effects
Men Over Age 75 Shouldn’t Be Screened For Prostate Cancer, Task Force Says
Quality Of Care Varies Widely For Prostate Cancer, Study Says
Prostatectomy Improves Outcome In Some Men
Risk of Relapse Continues After Five Years of Therapy
Two Breast Cancer Screening Methods Found Equivalent
Zometa Prevents Bone Loss In Premenopausal Women
Risk Assessment Key In Long-Term Treatment
Survey Finds Misconceptions About Cancer Worldwide
NCI Cooperative Group, Cancer Center Trials Listed
Trending Stories
- Harvey Risch, critic of COVID-19 response, tapped by White House to serve as chair of the President’s Cancer Panel
- Brown University reaches agreement with Trump administration to restore funding
- House passes Mikaela Naylon Give Kids a Chance Act—next step, the Senate
- Richard Pazdur left FDA to avoid being part of “the destruction of the American medical system”
- John Byrd brings blood cancer expertise to solid tumor, immunology powerhouse at UPMC
- Antonio Wolff, Mikala Egeblad named co-directors of Johns Hopkins Kimmel Cancer Center Breast and Gynecologic Cancer Program









